Indomethacin for Pancreatitis

VD
Overseen ByVu Dinh, MD, PhD
Age: 18+
Sex: Any
Trial Phase: Phase 4
Sponsor: University of California, San Francisco
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Prior Safety DataThis treatment has passed at least one previous human trial

What You Need to Know Before You Apply

What is the purpose of this trial?

This study is a randomized clinical trial evaluating the efficacy of rectal indomethacin in preventing post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis in patients undergoing biliary ERCP who have a history of prior biliary sphincterotomy. While rectal indomethacin has demonstrated benefits in preventing post-ERCP pancreatitis in high-risk patients, its utility in this specific patient subgroup remains unclear. This trial aims to determine whether prophylactic administration of indomethacin offers a measurable benefit over no intervention in this lower-risk population.

Eligible patients will be identified prior to their scheduled biliary ERCP and screened for inclusion criteria. Following informed consent, participants will be randomized to receive either rectal indomethacin or no indomethacin prior to the procedure.

Who Is on the Research Team?

ML

Michael Larsen, MD

Principal Investigator

University of California, San Francisco

Are You a Good Fit for This Trial?

This trial is for people scheduled to have a biliary ERCP procedure who have previously had a biliary sphincterotomy. Participants are screened before their procedure to make sure they meet the study requirements.

Inclusion Criteria

Ability to receive rectal medication
Ability and willingness to comply with all study procedures and follow-up requirements
Written informed consent (and assent when applicable) obtained from the subject or legal representative, with confirmed ability to comply with study requirements
See 2 more

Exclusion Criteria

Pregnant, breastfeeding, or unwilling to practice birth control during study participation
I have active GI bleeding or cannot safely take NSAIDs.
Presence of any condition or abnormality that compromises patient safety or data quality per Investigator opinion
See 4 more

What Are the Treatments Tested in This Trial?

Interventions

  • Indomethacin

Trial Overview

The study tests if giving rectal indomethacin before a biliary ERCP can help prevent pancreatitis, compared to not giving any medication. Patients are randomly assigned to receive either indomethacin or no treatment.

How Is the Trial Designed?

2

Treatment groups

Experimental Treatment

Active Control

Group I: IndomethacinExperimental Treatment1 Intervention
Group II: Digital Rectal ExamActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of California, San Francisco

Lead Sponsor

Trials
2,636
Recruited
19,080,000+